Alexander Kristen
SEC insider (Form 3/4/5 filer). CIK 0001878867. VP, Finance and Accounting at LEXICON PHARMACEUTICALS, INC. (LXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2025. Located in THE WOODLANDS, TX.
Companies Alexander Kristen has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, VP, Finance and Accounting
Alexander Kristen
CIK: 0001878867
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect10.6K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect15.9K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect19.9K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect17.9K shares at avg. $0.67$12K - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
185.5K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
185.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 10,617 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 15,926 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 19,887 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 17,862 | $0.67 | $11,968 | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 185,540 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 185,540 | - | - | Direct |
1-6 of 6 transactions